E
ZyVersa Therapeutics, Inc. ZVSA
$0.7899 -$0.0111-1.39%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Net Income 17.27% 96.48% 20.24% -185.18% 21.40%
Total Depreciation and Amortization -98.57% 300.00% 0.00% -4,465.38% 4,465.38%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 7.64% -99.78% 190.74% 48,552.21% -78.06%
Change in Net Operating Assets -6.10% -77.50% -78.96% -257.41% -35.13%
Cash from Operations 31.18% -369.60% 17.71% 26.84% -140.78%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -73.00% -100.00% -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 67.25% -- -- -1,720.33% -64.84%
Cash from Financing -71.67% 100.00% 7,801.73% 747.40% 244.96%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -99.75% -82.40% 76.12% 147.28% 392.88%
Weiss Ratings